GLP-1 receptor agonists and breast cancer risk in type 2 diabetes.

Authors

Guo Cheng, Greater Baltimore Medical Center
Amanda Ward, Greater Baltimore Medical Center (GBMC)

Document Type

Article

Publication Title

Journal of Clinical Oncology

DOI

https://doi.org/10.1200/JCO.2025.43.16_suppl.10557

Publication Date

5-28-2025

Recommended Citation

Guo Cheng et al. GLP-1 receptor agonists and breast cancer risk in type 2 diabetes.. JCO 43, 10557-10557(2025). DOI:10.1200/JCO.2025.43.16_suppl.10557